StockClub

BBOT

BBOTBridgeBio Oncology Therapeutics Inc.$ --
BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-46M USD
YoY -99.6%
Net Income
-42M USD
YoY -90.9%
EPS
-1.35$
YoY -43.6%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-42.1M
FY2024 Q2$-37.3M
$-37.3M
Q2
FY2024 Q3$-54.6M
$-54.6M
Q3
FY2024 Q4$-74.3M
$-74.3M
Q4
FY2025 Q1$-22.1M
$-22.1M
Q1
FY2025 Q2$-50.5M
$-50.5M
Q2
FY2025 Q3$-95.2M
$-95.2M
Q3
FY2025 Q4$-134M
$-134M
Q4
FY2026 Q1$-42.1M
$-42.1M
Q1
Actual
$-20.1M (-90.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025IN-LINE
Actual:$0
Est:$0
FY2025IN-LINE
$0

Analyst Estimates